Oxford’s FluoRok raises €26.64 million to scale fluorochemical production without hazardous hydrogen fluoride
FluoRok, an Oxford-based chemical manufacturing startup that has developed a patented process to produce fluorochemicals without using highly hazardous hydrogen fluoride (HF), has secured a €26.64 million ($30 million) Series A financing round. The round was led by Orano Ventures Fund/Supernova Invest, with participation from investor Bidra Innovation Ventures. Existing backers Oxford Science…
Oxford-based chemical startup FluoRok has secured €26.64 million ($30 million) in Series A funding to scale its innovative fluorochemical production process, which eliminates the use of hazardous hydrogen fluoride (HF). The financing round was led by Orano Ventures Fund/Supernova Invest, with participation from Bidra Innovation Ventures, Oxford Science Enterprises, BGF, GGF, Volta Energy Technologies, and the University of Oxford.
FluoRok's patented manufacturing platform bypasses the traditional, highly hazardous HF-based process used by the industry, instead using mechanical activation and base chemistry to extract fluorine from lower-grade minerals and industrial waste streams. The funding will enable FluoRok to transition from startup to scale-up, build demonstrator facilities for its reagents and battery electrolyte salts, expand its team, and deepen commercial partnerships.
The company aims to serve critical sectors like pharmaceuticals, agrochemicals, and lithium-ion battery manufacturing while addressing safety, supply, and cost risks associated with conventional fluorochemical production.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
